Molecular Diagnostics Market

Molecular Diagnostics Market (Product Type: Instruments, Reagents and Software and Services; Technology: PCR, In Situ Hybridization (ISH), Isothermal Nucleic Acid Amplification, Sequencing, DNA Microarrays and Others; Application: Infectious Diseases, Oncology and Genetic Testing, Neurological Diseases and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 to 2035

Molecular Diagnostics Market Outlook 2035

The global molecular diagnostics industry was valued at US$ 16.6 Bn in 2024
It is projected to grow at a CAGR of 9.1% from 2025 to 2035 and cross US$ 43.4 Bn by the end of 2035

Analysts’ Viewpoint Molecular Diagnostics Market

The molecular diagnostics market is expanding at a rapid pace due to rise in incidence of infectious diseases and cancer along with increasing frequency of genetic disorders, thereby resulting in increased need for quick and precise diagnostics. Technological developments in PCR, liquid biopsy, next generation sequencing (NGS), and point-of-care diagnostics are enhancing diagnostics efficiency and application areas, including advances in personalized medicine to cater to the market.

Molecular Diagnostics Market By Revanue 2020 To 2035

The global molecular diagnostics market has its limitations, including the capital cost of equipment and reagents, regulatory frameworks, reimbursement policies, and the fact that the developing parts of the world have limited skilled professionals.

The market for rapid diagnostics is projected to develop, including ascendance in certain segments like minimal residual disease (MRD) testing and companion diagnostics segments projected to realize the greatest growth revenue and consumption trends, and pharma companies pivoting diagnostics into point of need solutions.

Market Drivers	Rising Prevalence of Infectious and Chronic Diseases Technological Advances in PCR, NGS, Liquid Biopsy & AI Expansion of Point-of-Care (POC) Testing

Rising Prevalence of Infectious and Chronic Diseases expected to Drive Molecular Diagnostics Market Size

Molecular Diagnostics Market By Product 2020 To 2035

The rising incidence of chronic and infectious diseases is expected to propel growth of the molecular diagnostics market by increasing demand for quicker, more precise, and targeted diagnostic solutions. Infectious diseases that include COVID-19, HIV, Hepatitis, and respiratory infections require rapid detection in order to minimize the risk of transmission and initiate treatment at the earliest.

Molecular tests, for example PCR testing, have become essential tools in response to public health emergencies. For instance, as per the data published by Centers for Disease Control and Prevention in October 2024, 6 in 10 Americans are suffering from atleast one chronic disease, and 4 in 10 have two or more of them. It further states that sexually transmitted infections (STIs) continue to rise in the United States with over 2.5 million cases of gonorrhea, chlamydia, and syphilis in 2022

Technological Advances in PCR, NGS, Liquid Biopsy & AI Anticipated to Boost Molecular Diagnostics Market Expansion

The molecular diagnostics market is expected to increase on a tremendous note during the forecast period owing to development of new technologies such as next-generation sequencing (NGS), polymerase chain reaction (PCR), liquid biopsy, and artificial intelligence (AI). PCR and NGS have turned out to be highly sensitive and reliable platforms for detecting and genetically profiling cancer biomarkers and infectious agents. This rapid detection and diagnostic accuracy enhance clinical outcomes via early and correct diagnosis.

The new liquid biopsy methods are enhancing access to tumor-specific DNA and RNA testing that is obtained in a minimally invasive manner since it is taken from blood samples rather than tumor tissue samples, which is used for an invasive biopsy. The availability of minimally invasive tests impacts additional areas of molecular testing in oncology and personalized medicine while expanding the utility and scope of these tests.

Advancements in AI-driven analysis are improving the speed and increasing the rate of test interpretation by analyzing the data faster, decreasing error, and recommending and supporting clinical decision-making in both - clinical laboratory and point-of-care settings. These developments will fundamentally improve the speed and accuracy of tests and expand testing diagnosis to include smaller clinics, hospitals, and home or remote testing capabilities that take advantage of advanced molecular technologies.

Reagent Segment Driving Molecular Diagnostics Market Growth

The reagents segment dominates the global molecular diagnostics market due to its critical role in test accuracy and repeat usage. Reagents include enzymes, primers, probes, buffers, and the other chemical components essential for molecular assays such as PCR, sequencing, and isothermal amplification. Their recurring consumption in every diagnostic test drives consistent demand, thereby making this segment a major revenue contributor.

Technological advancements have led to the development of disease-specific reagent kits that enable early and precise detection of chronic and infectious diseases prevalent in Eastern Europe - such as tuberculosis, hepatitis, and cancer. Additionally, increasing investments in research and innovation, along with the rising prevalence of target diseases, have further expanded the reagents market.

Regional Outlook of Molecular Diagnostics Market

Molecular Diagnostics Market By Region 2020 To 2035

Leading Region	North America

North America is the torchbearer to the molecular diagnostics market due to a well-established healthcare infrastructure, technological advancements, and sizable investments in research and development.

Higher adoption rates of innovative diagnostic techniques, particularly in the U.S. and Canada, have further fueled market growth. Additionally, the presence of major biotechnology and pharmaceutical companies, along with supportive government initiatives and funding for infectious disease testing and precision medicine, have strengthened North America's position.

Analysis of Key Players in Molecular Diagnostics Market

F. Hoffmann-La Roche AG, Abbott, Illumina, Inc., Thermo Fisher Scientific Inc., Becton, Dickinson and Company (BD), llumina, Inc., bioMérieux, DiaSorin S.p.A., Hologic, Inc., SD Biosensor, Inc., QIAGEN N.V., QuidelOrtho, Siemens Healthineers AG, and others

Each of these players has been profiled in the molecular diagnostics industry research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments

In April 2025, Abbott announced the launch of its CE-marked HR HPV assay in Europe. The newly launched diagnostic assay includes self-collection of vaginal samples using the simpli-COLLECT HPV Collection Kit or the Evalyn Brush. The test is approved for use by healthcare providers either alone or in combination with a Pap test and helps HCPs to perform risk assessment by identifying HPV genotypes 16, 18, and 45 while reporting the concurrent detection of the other high-risk genotypes.
In September 2024, QIAGEN launched the QIAcuityDx Digital PCR System, a digital PCR tool for clinical diagnostics. The instrument and accessories are FDA-exempt in the U.S. and IVDR-certified for Europe. It offers precise quantitation of target DNA and RNA, thereby making it ideal for monitoring cancer progression. QIAGEN is expanding its application menu and partnering with pharmaceutical companies for companion diagnostics.

Molecular Diagnostics Market Snapshot

Attribute	Detail
Size in 2024	US$ 16.6 Bn
Forecast Value in 2035	US$ 43.4 Bn
CAGR	9.1%
Forecast Period	2025–2035
Historical Data Available for	2020–2023
Quantitative Units	US$ Bn for Value
Market Analysis	It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis.
Competition Landscape	Competition Matrix Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format	Electronic (PDF) + Excel
Segmentation	Product Type Instruments Reagents Software and Services Technology PCR In Situ Hybridization (ISH) Isothermal Nucleic Acid Amplification Sequencing DNA Microarrays Others (Mass spectrometry, Liquid Biopsy, etc.) Application Infectious Diseases Sexual Health Diseases Women’s Health Blood-borne Virus Respiratory Infections Healthcare-associated Infections Oncology and Genetic Testing Bladder Cancer Breast Cancer Prostate Cancer Colorectal Cancer Lung Cancer Others Neurological Diseases Others (Cardiovascular Diseases, etc.) End-user Hospitals & Clinics Diagnostic Laboratories Others (Research Institutes, etc.)
Regions Covered	North America Europe Asia Pacific Latin America Middle East & Africa
Countries Covered	U.S. Canada Germany U.K. France Italy Spain The Netherlands China India Japan South Korea Australia ASEAN Brazil Mexico Argentina GCC Countries South Africa
Companies Profiled	F. Hoffmann-La Roche AG Abbott Illumina, Inc. Thermo Fisher Scientific Inc. Becton, Dickinson and Company (BD) Illumina, Inc. bioMérieux DiaSorin S.p.A. Hologic, Inc. SD Biosensor, Inc. QIAGEN N.V. QuidelOrtho Siemens Healthineers AG Other Prominent Players
Customization Scope	Available upon request
Pricing	Available upon request

Frequently Asked Questions

How big was the global molecular diagnostics market in 2024?

The global molecular diagnostics market was valued at US$ 16.6 Bn in 2024

What is the projected size of the molecular diagnostics industry by 2035?

The molecular diagnostics market is projected to cross US$ 43.4 Bn by the end of 2035

What are the factors driving the molecular diagnostics market?

Rising prevalence of infectious and chronic diseases, technological advances in PCR, NGS, liquid biopsy & AI, and Expansion of Point-of-Care (POC) Testing

How is the molecular diagnostics market expected to grow during the forecast period?

It is anticipated to grow at a CAGR of 9.1% from 2025 to 2035

Which region is expected to dominate the molecular diagnostics market during the forecast period?

North America is expected to account for the largest share from 2025 to 2035

Who are the prominent molecular diagnostics providers?

Preface
- Market Definition and Scope
- Market Segmentation
- Key Research Objectives
- Research Highlights
Assumptions and Research Methodology
Executive Summary : Global Molecular Diagnostics Market
Market Overview
- Introduction
  - Product Type Definition
  - Industry Evolution/Developments
- Overview
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Global Molecular Diagnostics Market Analysis and Forecasts, 2020 - 2035
  - Market Revenue Projections (US$ Bn)
Key Insights
- Regulatory Landscape across Key Regions/Countries
- Market Trends
- PORTER’s Five Forces Analysis
- PESTEL Analysis
- Key Purchase Metrics for End-users
- Brand and Pricing Analysis
- Key Industry Events
- Technological Advancement
Global Molecular Diagnostics Market Analysis and Forecasts, By Product Type
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast By Product Type , 2020 - 2035
  - Instruments
  - Reagents
  - Software and Services
- Market Attractiveness By Product Type
Global Molecular Diagnostics Market Analysis and Forecasts, By Technology
- Introduction & Definition
- Key Findings / Developments
- Market Value Forecast By Technology, 2020 - 2035
  - PCR
  - In Situ Hybridization (ISH)
  - Isothermal Nucleic Acid Amplification
  - Sequencing
  - DNA Microarrays
  - Others
- Market Attractiveness By Technology
Global Molecular Diagnostics Market Analysis and Forecasts, By Application
- Introduction & Definition
- Key Findings / Developments
- Market Value Forecast By Application, 2020 - 2035
  - Infectious Diseases
    - Sexual Health Diseases
    - Women’s Health
    - Blood-borne Virus
    - Respiratory Infections
    - Healthcare-associated Infections
  - Oncology and Genetic Testing
    - Bladder Cancer
    - Breast Cancer
    - Prostate Cancer
    - Colorectal Cancer
    - Lung Cancer
    - Others
  - Neurological Diseases
  - Others
- Market Attractiveness By Application
Global Molecular Diagnostics Market Analysis and Forecasts, By End-user
- Introduction & Definition
- Key Findings / Developments
- Market Value Forecast By End-user, 2020 - 2035
  - Hospitals & Clinics
  - Diagnostic Laboratories
  - Others
- Market Attractiveness By End-user
Global Molecular Diagnostics Market Analysis and Forecasts, By Region
- Key Findings
- Market Value Forecast By Region
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East & Africa
- Market Attractiveness By Country/Region
North America Molecular Diagnostics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast By Product Type , 2020 - 2035
  - Instruments
  - Reagents
  - Software and Services
- Market Value Forecast By Technology, 2020 - 2035
  - PCR
  - In Situ Hybridization (ISH)
  - Isothermal Nucleic Acid Amplification
  - Sequencing
  - DNA Microarrays
  - Others
- Market Value Forecast By Application, 2020 - 2035
  - Infectious Diseases
    - Sexual Health Diseases
    - Women’s Health
    - Blood-borne Virus
    - Respiratory Infections
    - Healthcare-associated Infections
  - Oncology and Genetic Testing
    - Bladder Cancer
    - Breast Cancer
    - Prostate Cancer
    - Colorectal Cancer
    - Lung Cancer
    - Others
  - Neurological Diseases
  - Others
- Market Value Forecast By End-user, 2020 - 2035
  - Hospitals & Clinics
  - Diagnostic Laboratories
  - Others
- Market Value Forecast By Country, 2020 - 2035
  - U.S.
  - Canada
- Market Attractiveness Analysis
  - By Product Type
  - By Technology
  - By Application
  - By End-user
  - By Country
Europe Molecular Diagnostics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast By Product Type , 2020 - 2035
  - Instruments
  - Reagents
  - Software and Services
- Market Value Forecast By Technology, 2020 - 2035
  - PCR
  - In Situ Hybridization (ISH)
  - Isothermal Nucleic Acid Amplification
  - Sequencing
  - DNA Microarrays
  - Others
- Market Value Forecast By Application, 2020 - 2035
  - Infectious Diseases
    - Sexual Health Diseases
    - Women’s Health
    - Blood-borne Virus
    - Respiratory Infections
    - Healthcare-associated Infections
  - Oncology and Genetic Testing
    - Bladder Cancer
    - Breast Cancer
    - Prostate Cancer
    - Colorectal Cancer
    - Lung Cancer
    - Others
  - Neurological Diseases
  - Others
- Market Value Forecast By End-user, 2020 - 2035
  - Hospitals & Clinics
  - Diagnostic Laboratories
  - Others
- Market Value Forecast By Country/Sub-region, 2020 - 2035
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - The Netherlands
  - Rest of Europe
- Market Attractiveness Analysis
  - By Product Type
  - By Technology
  - By Application
  - By End-user
  - By Country/Sub-region
Asia Pacific Molecular Diagnostics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast By Product Type , 2020 - 2035
  - Instruments
  - Reagents
  - Software and Services
- Market Value Forecast By Technology, 2020 - 2035
  - PCR
  - In Situ Hybridization (ISH)
  - Isothermal Nucleic Acid Amplification
  - Sequencing
  - DNA Microarrays
  - Others
- Market Value Forecast By Application, 2020 - 2035
  - Infectious Diseases
    - Sexual Health Diseases
    - Women’s Health
    - Blood-borne Virus
    - Respiratory Infections
    - Healthcare-associated Infections
  - Oncology and Genetic Testing
    - Bladder Cancer
    - Breast Cancer
    - Prostate Cancer
    - Colorectal Cancer
    - Lung Cancer
    - Others
  - Neurological Diseases
  - Others
- Market Value Forecast By End-user, 2020 - 2035
  - Hospitals & Clinics
  - Diagnostic Laboratories
  - Others
- Market Value Forecast By Country/Sub-region, 2020 - 2035
  - China
  - Japan
  - India
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Market Attractiveness Analysis
  - By Product Type
  - By Technology
  - By Application
  - By End-user
  - By Country/Sub-region
Latin America Molecular Diagnostics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast By Product Type , 2020 - 2035
  - Instruments
  - Reagents
  - Software and Services
- Market Value Forecast By Technology, 2020 - 2035
  - PCR
  - In Situ Hybridization (ISH)
  - Isothermal Nucleic Acid Amplification
  - Sequencing
  - DNA Microarrays
  - Others
- Market Value Forecast By Application, 2020 - 2035
  - Infectious Diseases
    - Sexual Health Diseases
    - Women’s Health
    - Blood-borne Virus
    - Respiratory Infections
    - Healthcare-associated Infections
  - Oncology and Genetic Testing
    - Bladder Cancer
    - Breast Cancer
    - Prostate Cancer
    - Colorectal Cancer
    - Lung Cancer
    - Others
  - Neurological Diseases
  - Others
- Market Value Forecast By End-user, 2020 - 2035
  - Hospitals & Clinics
  - Diagnostic Laboratories
  - Others
- Market Value Forecast By Country/Sub-region, 2020 - 2035
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Market Attractiveness Analysis
  - By Product Type
  - By Technology
  - By Application
  - By End-user
  - By Country/Sub-region
Middle East & Africa Molecular Diagnostics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast By Product Type , 2020 - 2035
  - Instruments
  - Reagents
  - Software and Services
- Market Value Forecast By Technology, 2020 - 2035
  - PCR
  - In Situ Hybridization (ISH)
  - Isothermal Nucleic Acid Amplification
  - Sequencing
  - DNA Microarrays
  - Others
- Market Value Forecast By Application, 2020 - 2035
  - Infectious Diseases
    - Sexual Health Diseases
    - Women’s Health
    - Blood-borne Virus
    - Respiratory Infections
    - Healthcare-associated Infections
  - Oncology and Genetic Testing
    - Bladder Cancer
    - Breast Cancer
    - Prostate Cancer
    - Colorectal Cancer
    - Lung Cancer
    - Others
  - Neurological Diseases
  - Others
- Market Value Forecast By End-user, 2020 - 2035
  - Hospitals & Clinics
  - Diagnostic Laboratories
  - Others
- Market Value Forecast By Country/Sub-region, 2020 - 2035
  - GCC Countries
  - South Africa
  - Rest of Middle East & Africa
- Market Attractiveness Analysis
  - By Product Type
  - By Technology
  - By Application
  - By End-user
  - By Country/Sub-region
Competition Landscape
- Market Player – Competition Matrix (By Tier and Size of companies)
- Market Share Analysis By Company (2024)
- Company Profiles
  - F. Hoffmann-La Roche AG
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Abbott
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Illumina, Inc.
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Thermo Fisher Scientific Inc.
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Becton, Dickinson and Company (BD)
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Illumina, Inc.
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - bioMérieux
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - DiaSorin S.p.A.
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Hologic, Inc.
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - SD Biosensor, Inc.
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - QIAGEN N.V.
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - QuidelOrtho
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Siemens Healthineers AG
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Other Prominent Players
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments

List of Tables

Table 01: Global Molecular Diagnostics Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
Table 02: Global Molecular Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2020 to 2035
Table 03: Global Molecular Diagnostics Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
Table 04: Global Molecular Diagnostics Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
Table 05: Global Molecular Diagnostics Market Value (US$ Bn) Forecast, By Region, 2020 to 2035
Table 06: North America Molecular Diagnostics Market Value (US$ Bn) Forecast, by Country, 2020-2035
Table 07: North America Molecular Diagnostics Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
Table 08: North America Molecular Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2020 to 2035
Table 09: North America Molecular Diagnostics Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
Table 10: North America Molecular Diagnostics Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
Table 11: Europe Molecular Diagnostics Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
Table 12: Europe Molecular Diagnostics Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
Table 13: Europe Molecular Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2020 to 2035
Table 14: Europe Molecular Diagnostics Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
Table 15: Europe Molecular Diagnostics Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
Table 16: Asia Pacific Molecular Diagnostics Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
Table 17: Asia Pacific Molecular Diagnostics Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
Table 18: Asia Pacific Molecular Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2020 to 2035
Table 19: Asia Pacific Molecular Diagnostics Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
Table 20: Asia Pacific Molecular Diagnostics Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
Table 21: Latin America Molecular Diagnostics Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
Table 22: Latin America Molecular Diagnostics Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
Table 23: Latin America Molecular Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2020 to 2035
Table 24: Latin America Molecular Diagnostics Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
Table 25: Latin America Molecular Diagnostics Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
Table 26: Middle East & Africa Molecular Diagnostics Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
Table 27: Middle East & Africa Molecular Diagnostics Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
Table 28: Middle East & Africa Molecular Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2020 to 2035
Table 29: Middle East & Africa Molecular Diagnostics Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
Table 30: Middle East & Africa Molecular Diagnostics Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035

List of Figures

Figure 01: Global Molecular Diagnostics Market Value Share Analysis, By Product Type, 2024 and 2035
Figure 02: Global Molecular Diagnostics Market Attractiveness Analysis, By Product Type, 2025 to 2035
Figure 03: Global Molecular Diagnostics Market Revenue (US$ Bn), by Instruments, 2020 to 2035
Figure 04: Global Molecular Diagnostics Market Revenue (US$ Bn), by Reagents, 2020 to 2035
Figure 05: Global Molecular Diagnostics Market Revenue (US$ Bn), by Software and Services, 2020 to 2035
Figure 06: Global Molecular Diagnostics Market Value Share Analysis, by Technology, 2024 and 2035
Figure 07: Global Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2025 to 2035
Figure 08: Global Molecular Diagnostics Market Revenue (US$ Bn), by PCR, 2020 to 2035
Figure 09: Global Molecular Diagnostics Market Revenue (US$ Bn), by In Situ Hybridization (ISH), 2020 to 2035
Figure 10: Global Molecular Diagnostics Market Revenue (US$ Bn), by Isothermal Nucleic Acid Amplification, 2020 to 2035
Figure 11: Global Molecular Diagnostics Market Revenue (US$ Bn), by Sequencing, 2020 to 2035
Figure 12: Global Molecular Diagnostics Market Revenue (US$ Bn), by DNA Microarrays, 2020 to 2035
Figure 13: Global Molecular Diagnostics Market Revenue (US$ Bn), by Others, 2020 to 2035
Figure 14: Global Molecular Diagnostics Market Value Share Analysis, by Application, 2024 and 2035
Figure 15: Global Molecular Diagnostics Market Attractiveness Analysis, by Application, 2025 to 2035
Figure 16: Global Molecular Diagnostics Market Revenue (US$ Bn), by Infectious Diseases, 2020 to 2035
Figure 17: Global Molecular Diagnostics Market Revenue (US$ Bn), by Oncology and Genetic Testing, 2020 to 2035
Figure 18: Global Molecular Diagnostics Market Revenue (US$ Bn), by Neurological Diseases, 2020 to 2035
Figure 19: Global Molecular Diagnostics Market Revenue (US$ Bn), by Others, 2020 to 2035
Figure 20: Global Molecular Diagnostics Market Value Share Analysis, By End-user, 2024 and 2035
Figure 21: Global Molecular Diagnostics Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 22: Global Molecular Diagnostics Market Revenue (US$ Bn), by Hospitals & Clinics, 2020 to 2035
Figure 23: Global Molecular Diagnostics Market Revenue (US$ Bn), by Diagnostic Laboratories, 2020 to 2035
Figure 24: Global Molecular Diagnostics Market Revenue (US$ Bn), by Others, 2020 to 2035
Figure 25: Global Molecular Diagnostics Market Value Share Analysis, By Region, 2024 and 2035
Figure 26: Global Molecular Diagnostics Market Attractiveness Analysis, By Region, 2025 to 2035
Figure 27: North America Molecular Diagnostics Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 28: North America Molecular Diagnostics Market Value Share Analysis, by Country, 2024 and 2035
Figure 29: North America Molecular Diagnostics Market Attractiveness Analysis, by Country, 2025 to 2035
Figure 30: North America Molecular Diagnostics Market Value Share Analysis, By Product Type, 2024 and 2035
Figure 31: North America Molecular Diagnostics Market Attractiveness Analysis, By Product Type, 2025 to 2035
Figure 32: North America Molecular Diagnostics Market Value Share Analysis, by Technology, 2024 and 2035
Figure 33: North America Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2025 to 2035
Figure 34: North America Molecular Diagnostics Market Value Share Analysis, by Application, 2024 and 2035
Figure 35: North America Molecular Diagnostics Market Attractiveness Analysis, by Application, 2025 to 2035
Figure 36: North America Molecular Diagnostics Market Value Share Analysis, By End-user, 2024 and 2035
Figure 37: North America Molecular Diagnostics Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 38: Europe Molecular Diagnostics Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 39: Europe Molecular Diagnostics Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 40: Europe Molecular Diagnostics Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
Figure 41: Europe Molecular Diagnostics Market Value Share Analysis, By Product Type, 2024 and 2035
Figure 42: Europe Molecular Diagnostics Market Attractiveness Analysis, By Product Type, 2025 to 2035
Figure 43: Europe Molecular Diagnostics Market Value Share Analysis, by Technology, 2024 and 2035
Figure 44: Europe Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2025 to 2035
Figure 45: Europe Molecular Diagnostics Market Value Share Analysis, by Application, 2024 and 2035
Figure 46: Europe Molecular Diagnostics Market Attractiveness Analysis, by Application, 2025 to 2035
Figure 47: Europe Molecular Diagnostics Market Value Share Analysis, By End-user, 2024 and 2035
Figure 48: Europe Molecular Diagnostics Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 49: Asia Pacific Molecular Diagnostics Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 50: Asia Pacific Molecular Diagnostics Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 51: Asia Pacific Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
Figure 52: Asia Pacific Molecular Diagnostics Market Value Share Analysis, By Product Type, 2024 and 2035
Figure 53: Asia Pacific Molecular Diagnostics Market Attractiveness Analysis, By Product Type, 2025 to 2035
Figure 54: Asia Pacific Molecular Diagnostics Market Value Share Analysis, by Technology, 2024 and 2035
Figure 55: Asia Pacific Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2025 to 2035
Figure 56: Asia Pacific Molecular Diagnostics Market Value Share Analysis, by Application, 2024 and 2035
Figure 57: Asia Pacific Molecular Diagnostics Market Attractiveness Analysis, by Application, 2025 to 2035
Figure 58: Asia Pacific Molecular Diagnostics Market Value Share Analysis, By End-user, 2024 and 2035
Figure 59: Asia Pacific Molecular Diagnostics Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 60: Latin America Molecular Diagnostics Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 61: Latin America Molecular Diagnostics Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 62: Latin America Molecular Diagnostics Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
Figure 63: Latin America Molecular Diagnostics Market Value Share Analysis, By Product Type, 2024 and 2035
Figure 64: Latin America Molecular Diagnostics Market Attractiveness Analysis, By Product Type, 2025 to 2035
Figure 65: Latin America Molecular Diagnostics Market Value Share Analysis, by Technology, 2024 and 2035
Figure 66: Latin America Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2025 to 2035
Figure 67: Latin America Molecular Diagnostics Market Value Share Analysis, by Application, 2024 and 2035
Figure 68: Latin America Molecular Diagnostics Market Attractiveness Analysis, by Application, 2025 to 2035
Figure 69: Latin America Molecular Diagnostics Market Value Share Analysis, By End-user, 2024 and 2035
Figure 70: Latin America Molecular Diagnostics Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 71: Middle East & Africa Molecular Diagnostics Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 72: Middle East & Africa Molecular Diagnostics Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 73: Middle East & Africa Molecular Diagnostics Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
Figure 74: Middle East & Africa Molecular Diagnostics Market Value Share Analysis, By Product Type, 2024 and 2035
Figure 75: Middle East & Africa Molecular Diagnostics Market Attractiveness Analysis, By Product Type, 2025 to 2035
Figure 76: Middle East & Africa Molecular Diagnostics Market Value Share Analysis, by Technology, 2024 and 2035
Figure 77: Middle East & Africa Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2025 to 2035
Figure 78: Middle East & Africa Molecular Diagnostics Market Value Share Analysis, by Application, 2024 and 2035
Figure 79: Middle East & Africa Molecular Diagnostics Market Attractiveness Analysis, by Application, 2025 to 2035
Figure 80: Middle East & Africa Molecular Diagnostics Market Value Share Analysis, By End-user, 2024 and 2035
Figure 81: Middle East & Africa Molecular Diagnostics Market Attractiveness Analysis, By End-user, 2025 to 2035